YoungSolvers Webinar: Introduction to SeeSAR and infiniSee


Tue, 15 Jun 2021, 16:00 CEST (Berlin)

Alexander Neumann, BioSolveIT

YoungSolvers Webinar: Introduction to SeeSAR and infiniSee

In this YoungSolvers 101 webinar you will learn the basics how to operate within SeeSAR and infiniSee. We give an introduction into the different modes of SeeSAR including how to edit your protein and ligand. Additional insights into the science behind the application will support you in your future projects and decision-making processes.

Topics of this webinar (selection):

  • Detect binding sites at your target
  • How to create and modify a ligand
  • Basics of molecular docking
  • How to assess your protein-ligand complex
  • How to find accessible ligands

Level: Beginner

Slides PDF

Current news

Recap DrugSpace Spring 2021: Recordings Available
September 16, 2021 19:03
A few months have passed since the DrugSpace Symposium Spring and the results and discussions are still echoing. The speakers and participants made this event a pioneering success in the field of innovative drug hunting methods and strategies for medicinal chemistry enthusiasts. Under the slogan ‘Targets, Compounds, Spaces’, speakers across...
Read on
Covalent Set Update: ChemDiv Library with over 41k Entries
September 14, 2021 11:35
As of today, BioSolveIT features another collaboration with a renowned expert and global leader in drug discovery chemistry. Together with ChemDiv we have processed and translated their huge library of compounds containing a covalent warhead into a ready-to-dock format for SeeSAR to be explored with covalent docking. The set features...
Read on
Reaxense Covalent Compound Library Now Available
September 6, 2021 13:04
Reaxense and BioSolveIT have teamed up and processed a new covalent compound library into a user-friendly format. Reaxense offers over 12,000 unique molecules containing at least one covalent warhead, as well as many other project-focused sets and libraries. Too great of a potential to be missed out! For your convenience,...
Read on